Sandra Philipp
Hochschule der Polizei des Landes Brandenburg(DE)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Asthma and respiratory diseases, Autoimmune and Inflammatory Disorders Research, Autoimmune Bullous Skin Diseases
Most-Cited Works
- → Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis(2017)506 cited
- → IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not(2009)403 cited
- → Immunopathogenesis of psoriasis(2007)370 cited
- → S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update(2012)271 cited
- → Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa(2012)249 cited
- → Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study(2015)222 cited
- → Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis(2020)203 cited
- → Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study(2018)181 cited
- → The Th17 cytokine IL‐22 induces IL‐20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis(2009)175 cited
- → IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis(2014)158 cited